Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Clinical trial NCT05342389 · UNKNOWN

Trial details

NCT number: NCT05342389
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Gastric Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma

Start date: 2022-05-01
Primary completion: 2023-05-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.